Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | DFX117 |
Synonyms | |
Therapy Description |
DFX117 is a dual inhibitor that blocks Met and selectively inhibits Pik3ca kinase activity, which potentially results in inhibition of cell proliferation, and induction of cell cycle arrest and apoptosis (PMID: 31060329, PMID: 28800461). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
DFX117 | DFX-117|DFX 117 | MET Inhibitor 59 PIK3CA inhibitor 26 | DFX117 is a dual inhibitor that blocks Met and selectively inhibits Pik3ca kinase activity, which potentially results in inhibition of cell proliferation, and induction of cell cycle arrest and apoptosis (PMID: 31060329, PMID: 28800461). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|